SPP1 and metabolic dysfunction-associated steatohepatitis: More recently osteopontin has been implicated as a key player in the pathogenesis of NASH, a disease characterized by an accumulation of fat in the liver, along with inflammation, hepatocyte ballooning and hepatic fibrosis.